前列腺癌预后模型研究进展
Advances in prognostic modeling of prostate cancer
周魏栋 1王英磊 2梅延辉 3徐延凯 2巩永凤 4赵升田5
作者信息
- 1. 滨州医学院第二临床医学院,山东烟台 264003
- 2. 滨州医学院烟台附属医院泌尿外科,山东烟台 264100
- 3. 滨州医学院附属医院泌尿外科,山东滨州 256603
- 4. 滨州医学院第二临床医学院,山东烟台 264003;肾脏病防治分子医学山东省工程研究中心,山东烟台 264003
- 5. 滨州医学院第二临床医学院,山东烟台 264003;肾脏病防治分子医学山东省工程研究中心,山东烟台 264003;山东省泌尿系器官及其功能重建工程实验室,山东济南 250021;山东第一医科大学附属省立医院,山东济南 250021
- 折叠
摘要
前列腺癌是男性最常见的癌症之一,其进展及预后受多种因素的影响.前列腺癌预后模型的研究对于患者的治疗规划和生存质量至关重要.模型的建立主要依赖于患者临床因素,如:TNM分期、格里森评分及前列腺特异性抗原等.随着研究的不断深入,预后模型因纳入更多的预后因素不断更新完善.本文从前列腺癌预后模型发展史、不同类型前列腺癌预后模型等方面进行综述,比较不同模型的适用性及优缺点,以期在临床上为不同的患者选择合适的预后模型提供参考.
Abstract
Prostate cancer is one of the most common cancers among males,and its progression and prognosis are in-fluenced by various factors.The research on prognosis models for prostate cancer is crucial for patients' treatment planning and quality of life.The establishment of these models mainly relies on clinical factors such as TNM staging,Gleason score,and PSA.As research continues to progress,prognosis models are constantly updated and improved by incorporat-ing more prognostic factors.This article reviews the development history of prostate cancer prognosis models,different types of prognosis models for prostate cancer,and compares their applicability,advantages,and disadvantages,aiming to provide a reference for selecting suitable prognosis models for different patients in clinical practice.
关键词
前列腺癌/预后/模型/临床决策Key words
prostate cancer/prognosis/model/clinical decision引用本文复制引用
出版年
2024
NETL
NSTL
万方数据